# Duration of Antibiotic Therapy in Acute Kidney Graft Pyelonephritis (AGPN): Effect on the Risk of Recurrence

> **NCT06848816** · — · ACTIVE_NOT_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 500 (estimated)

## Conditions studied

- Pyelonephritis Acute
- Kidney Transplantation Recipients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06848816
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06848816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06848816, "Duration of Antibiotic Therapy in Acute Kidney Graft Pyelonephritis (AGPN): Effect on the Risk of Recurrence". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06848816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*